Article
Advances in Circulating Tumor DNA Analysis.
Advances in clinical chemistry - 1 Jan 2000
Perakis Samantha, Auer Martina, Belic Jelena, Heitzer Ellen
Abstract excerpt
The analysis of cell-free circulating tumor DNA (ctDNA) is a very promising tool and might revolutionize cancer care with respect to early detection, identification of minimal residual disease, assessment of treatment response, and monitoring tumor evolution. ctDNA analysis, often referred to as "liquid biopsy" offers what tissue biopsies cannot-a continuous monitoring of tumor-specific changes during the entire...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
